(Q33966353)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

David A Shapiro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Sean Renock

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Elaine Arrington

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Louis A Chiodo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Li-Xin Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

David R Sibley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bryan L Roth

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

21 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Neuropsychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1400-1411

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300203

4 November 2019

exact match

0 references

cites work

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Does olanzapine have antidepressant properties? A retrospective preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Aripiprazole: profile on efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Antipsychotics: impact on prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Multiple serotonin receptors: clinical and experimental aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Environmental-dependent acceleration of a developmental switch: the floral transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Antagonism of the five cloned human muscarinic cholinergic receptors expressed in CHO-K1 cells by antidepressants and antihistaminics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Partial dopamine agonists in the treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

Muscarinic m4 receptor activation by some atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

The Role of Serotonin Receptor Subtypes in the Behavioural Effects of Neuroleptic Drugs. A Paw Test Study in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Cell-type specific effects of endocytosis inhibitors on 5-hydroxytryptamine(2A) receptor desensitization and resensitization reveal an arrestin-, GRK2-, and GRK5-independent mode of regulation in human embryonic kidney 293 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Serotonin in migraine: theories, animal models and emerging therapies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Peptides and psychiatry, Part 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Reduced satiating effect of d -fenfluramine in serotonin 5-HT 2C receptor mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300203

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12784105%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 November 2019

0 references

1 reference